Human SEMA4F/M-SEMA/m-Sema-M ORF/cDNA clone-Lentivirus particle (NM_004263)

Cat. No.: vGMLV000245

Pre-made Human SEMA4F/M-SEMA/m-Sema-M Lentiviral expression plasmid for SEMA4F lentivirus packaging, SEMA4F lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.

The GM Vector Core (GMVC) specializes in custom lentivirus development and offers a range of lentivirus manufacturing solutions, leveraging state-of-the-art processes. Learn more about our services.

Target products collection

Go to SEMA4F/M-SEMA products collection>>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdf MSDS
pdf Datasheet

Product information

Catalog No. Product Name lentivirus Grade lentivirus quantity
vGMLV000245 Human SEMA4F Lentivirus particle Pilot Grade 1.0E+8TU
5.0E+8TU
1.0E+9TU
Research Grade 1.0E+8TU
5.0E+8TU
1.0E+9TU
GMP-like Grade inquiry
GMP Grade inquiry


Product Description

Catalog ID vGMLV000245
Gene Name SEMA4F
Accession Number NM_004263
Gene ID 10505
Species Human
Product Type Lentivirus particle (overexpression)
Insert Length 2313 bp
Gene Alias M-SEMA,m-Sema-M,PRO2353,S4F,SEMAM,SEMAW
Fluorescent Reporter ZsGreen
Mammalian Cell Selection Puromyocin
Fusion Tag 3xflag (C-Terminal)
Promoter CMV
Resistance Amplicin
ORF Nucleotide Sequence ATGCCGGCCTCTGCTGCGCGGCCCCGCCCGGGTCCCGGGCAGCCTACAGCCTCGCCCTTCCCGCTACTGCTGCTGGCGGTGCTGAGCGGCCCGGTATCCGGCCGCGTCCCCCGCTCGGTGCCCAGAACCTCGCTTCCAATCTCTGAGGCTGACTCCTGTCTCACCCGGTTCGCAGTCCCTCACACATACAATTACTCTGTTCTCCTTGTGGATCCTGCCTCCCACACACTTTATGTTGGCGCCCGGGACACCATCTTCGCTTTATCCCTGCCCTTCTCAGGGGAGAGACCCCGCAGGATTGACTGGATGGTTCCTGAGGCTCACAGACAGAACTGTAGGAAGAAAGGCAAGAAAGAGGACGAATGTCACAATTTTGTCCAGATTCTCGCCATTGCCAATGCCTCTCACCTCCTCACTTGTGGCACCTTCGCTTTTGATCCGAAGTGCGGGGTTATTGATGTGTCCAGGTTCCAGCAGGTTGAAAGACTTGAGAGTGGCCGGGGGAAATGTCCTTTTGAGCCAGCTCAGCGGTCAGCAGCTGTAATGGCTGGGGGGGTCCTCTATGCTGCCACTGTGAAAAACTACCTGGGGACGGAGCCAATTATCACCAGAGCAGTGGGTCGTGCCGAGGACTGGATTCGGACAGATACCTTGCCTTCCTGGCTGAACGCCCCAGCCTTTGTCGCAGCCGTGGCCTTGAGCCCAGCCGAATGGGGGGATGAAGATGGAGACGACGAAATCTACTTCTTCTTTACGGAGACTTCCCGAGCATTTGACTCATACGAGCGCATTAAAGTCCCACGGGTGGCCCGTGTGTGTGCGGGGGACCTCGGGGGCCGGAAGACCCTCCAGCAGAGATGGACGACGTTTTTGAAAGCTGACCTGCTCTGTCCAGGGCCTGAGCATGGCCGGGCCTCCAGTGTCCTGCAGGATGTTGCTGTGCTTCGACCTGAGCTTGGGGCAGGGACTCCCATCTTTTATGGCATCTTTTCTTCCCAGTGGGAGGGGGCTACTATCTCTGCTGTCTGTGCCTTCCGACCACAAGACATTCGGACAGTGCTGAATGGTCCCTTCAGAGAACTAAAACATGACTGCAACAGAGGACTGCCTGTCGTGGACAATGATGTGCCCCAGCCCAGACCTGGAGAGTGCATCACCAACAACATGAAGCTCCGGCACTTTGGCTCATCTCTCTCCCTGCCTGACCGCGTACTCACCTTCATCCGGGACCACCCACTCATGGACAGGCCAGTGTTTCCAGCTGATGGCCACCCCCTGCTGGTCACTACAGATACAGCCTATCTCAGAGTCGTGGCCCACAGGGTGACCAGCCTCTCAGGGAAAGAGTATGATGTGCTCTACCTGGGGACAGAGGATGGACACCTCCACCGAGCAGTGCGGATCGGAGCTCAGCTCAGCGTTCTTGAAGATCTGGCCTTATTCCCAGAGCCACAGCCAGTTGAGAACATGAAATTGTACCACAGCTGGCTCCTGGTTGGCTCCCGTACTGAGGTGACACAAGTGAATACAACCAACTGTGGCCGTCTCCAGAGCTGCTCAGAGTGCATCCTGGCCCAGGACCCAGTCTGTGCCTGGAGCTTCCGGCTGGATGAGTGTGTGGCCCATGCCGGGGAGCACCGAGGGTTGGTCCAAGACATAGAGTCAGCAGATGTCTCCTCTTTGTGTCCTAAAGAGCCTGGAGAACGTCCAGTAGTGTTTGAAGTTCCCGTGGCTACAGCTGCGCATGTGGTCTTGCCATGTTCTCCAAGCTCAGCATGGGCATCCTGTGTGTGGCACCAGCCCAGTGGAGTGACTGCACTCACCCCCCGGCGGGATGGACTGGAGGTGGTGGTGACCCCAGGGGCCATGGGCGCTTATGCCTGTGAATGTCAGGAGGGTGGGGCAGCCCATGTGGTAGCAGCTTACAGCTTGGTATGGGGCAGCCAGCGAGATGCTCCGAGCCGGGCCCACACAGTGGGGGCGGGACTGGCTGGCTTCTTCTTGGGGATTCTCGCAGCATCCCTGACTCTCATTCTGATTGGTCGGCGTCAGCAGCGACGGCGACAGAGGGAACTTCTGGCTAGAGACAAGGTGGGCCTGGACCTGGGGGCTCCACCTTCTGGGACCACAAGCTACAGCCAAGACCCTCCCTCCCCCTCTCCTGAAGATGAGCGGTTGCCGCTGGCCCTGGCCAAGAGGGGCAGTGGCTTTGGTGGATTCTCACCACCCTTCCTGCTTGATCCTTGCCCAAGCCCAGCCCACATTCGGCTAACTGGGGCTCCTCTAGCCACATGTGATGAAACATCCATCTAG
ORF Protein Sequence MPASAARPRPGPGQPTASPFPLLLLAVLSGPVSGRVPRSVPRTSLPISEADSCLTRFAVPHTYNYSVLLVDPASHTLYVGARDTIFALSLPFSGERPRRIDWMVPEAHRQNCRKKGKKEDECHNFVQILAIANASHLLTCGTFAFDPKCGVIDVSRFQQVERLESGRGKCPFEPAQRSAAVMAGGVLYAATVKNYLGTEPIITRAVGRAEDWIRTDTLPSWLNAPAFVAAVALSPAEWGDEDGDDEIYFFFTETSRAFDSYERIKVPRVARVCAGDLGGRKTLQQRWTTFLKADLLCPGPEHGRASSVLQDVAVLRPELGAGTPIFYGIFSSQWEGATISAVCAFRPQDIRTVLNGPFRELKHDCNRGLPVVDNDVPQPRPGECITNNMKLRHFGSSLSLPDRVLTFIRDHPLMDRPVFPADGHPLLVTTDTAYLRVVAHRVTSLSGKEYDVLYLGTEDGHLHRAVRIGAQLSVLEDLALFPEPQPVENMKLYHSWLLVGSRTEVTQVNTTNCGRLQSCSECILAQDPVCAWSFRLDECVAHAGEHRGLVQDIESADVSSLCPKEPGERPVVFEVPVATAAHVVLPCSPSSAWASCVWHQPSGVTALTPRRDGLEVVVTPGAMGAYACECQEGGAAHVVAAYSLVWGSQRDAPSRAHTVGAGLAGFFLGILAASLTLILIGRRQQRRRQRELLARDKVGLDLGAPPSGTTSYSQDPPSPSPEDERLPLALAKRGSGFGGFSPPFLLDPCPSPAHIRLTGAPLATCDETSI

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    Category Cat No. Products Name
    Target Antibody GM-Tg-g-MP1501-Ab Anti-SEM4F/ SEMA4F/ M-SEMA monoclonal antibody
    Target Antigen GM-Tg-g-MP1501-Ag SEMA4F VLP (virus-like particle)
    ORF Viral Vector pGMLV000245 Human SEMA4F Lentivirus plasmid
    ORF Viral Vector vGMLV000245 Human SEMA4F Lentivirus particle


    Target information

    Target ID GM-MP1501
    Target Name SEMA4F
    Gene Group Identifier
    （Target Gene ID in Homo species)         		10505
    Gene ID 100068980 (Equus caballus), 101088923 (Felis catus), 10505 (Homo sapiens), 20355 (Mus musculus)
    29745 (Rattus norvegicus), 483098 (Canis lupus familiaris), 530018 (Bos taurus), 710297 (Macaca mulatta)
    Gene Symbols & Synonyms SEMA4F,Sema4f,S4F,SEMAM,SEMAW,M-SEMA,PRO2353,m-Sema-M,Sema W
    Target Alternative Names M-SEMA,PRO2353,S4F,SEMA4F,SEMAM,SEMAW,Sema W,Sema4f,Semaphorin-4F,Semaphorin-M (Sema M),Semaphorin-W (Sema W),m-Sema-M
    Uniprot Accession O95754,Q9Z123,Q9Z143
    Additional SwissProt Accessions: O95754,Q9Z123,Q9Z143
    Uniprot Entry Name
    Protein Sub-location Transmembrane Protein
    Category
    Disease
    Disease from KEGG Axon guidance
    Gene Ensembl ENSECAG00000010510, ENSG00000135622, ENSMUSG00000000627, ENSCAFG00845017211, ENSBTAG00000006989, ENSMMUG00000005149
    Target Classification


    About GMVC

    GDU

    GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.